Cristcot Inc

Alcresta Therapeutics, Inc., based in Waltham, MA, is dedicated to developing enzyme-based products that address fat malabsorption in patients requiring enteral nutrition, particularly those with rare diseases. Their flagship product, RELiZORB, features a patented microbead enzyme technology designed to facilitate fat digestion and absorption in individuals unable to fully benefit from standard enteral formulas. Serving both children and adults, Alcresta's solutions target conditions such as cystic fibrosis, short bowel syndrome, and pancreatitis. Through clinical trials and a pediatric patient registry, the company aims to enhance the quality of life for patients facing complex nutritional challenges. Generated from the website

Smith & Nephew develops and markets advanced medical devices that help healthcare professionals treat patients more effectively and patients get back to their normal lives faster. Our dedicated Global Business Units.

Founded in 1838, Codman & Shurtleff develops and markets a wide range of diagnostic and therapeutic products for the treatment of central nervous system disorders. Its products include drug pumps, cerebrospinal fluid shunts, neurological monitoring devices, electrosurgical systems and a variety of surgical instruments, including bipolar generators, forceps, retraction components, clamps, bayonet handles, graft drivers and pronged blades. It is a subsidiary of Johnson & Johnson, which is a global manufacturer and supplier of pharmaceutical products, medical devices and consumer packaged goods. The company supports the corporate marketing programs of Johnson & Johnson and offers support services to hospitals, assisted living facilities, educational institutions and care centers. Codman & Shurtleff is headquartered in Raynham, Mass.